Evidence map›Paper›PMID 34626533›Full record

ReviewRadiology and oncology2021

Target motion management in breast cancer radiation therapy.

Elham Piruzan, Naser Vosoughi, Seied Rabi Mahdavi, Leila Khalafi, Hojjat Mahani

Abstract readReview
In one paragraph

Review in Radiology and oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Particle radiotherapy for breast cancer.Frontiers in oncology · 2023
    Review
  11. Article
  12. [Prediction of respiratory motion based on sequential embedding combined with relational embedding].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elham PiruzanDepartment of Energy Engineering, Sharif University of Technology, Tehran, Iran.
Naser VosoughiDepartment of Energy Engineering, Sharif University of Technology, Tehran, Iran.
Seied Rabi MahdaviRadiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Leila KhalafiRadiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hojjat MahaniRadiation Applications Research School, Nuclear Science and Technology Research Institute, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver the last two decades, breast cancer remains the main cause of cancer deaths in women. To treat this type of cancer, radiation therapy (RT) has proved to be efficient. RT for breast cancer is, however, challenged by intrafractional motion caused by respiration. The problem is more severe for the left-sided breast cancer due to the proximity to the heart as an organ-at-risk. While particle therapy results in superior dose characteristics than conventional RT, due to the physics of particle interactions in the body, particle therapy is more sensitive to target motion.

conclusionsThis review highlights current and emerging strategies for the management of intrafractional target motion in breast cancer treatment with an emphasis on particle therapy, as a modern RT technique. There are major challenges associated with transferring real-time motion monitoring technologies from photon to particles beams. Surface imaging would be the dominant imaging modality for real-time intrafractional motion monitoring for breast cancer. The magnetic resonance imaging (MRI) guidance and ultra high dose rate (FLASH)-RT seem to be state-of-the-art approaches to deal with 4D RT for breast cancer.

Indexed as

Breast NeoplasmsRadiotherapy, Image-GuidedFemaleHumansMovementbreast cancerintrafractional movementparticle therapytarget motion

Identifiers

PMID34626533
PMCPMC8647788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.